Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor
1996

EGF and TGF-alpha Levels in Bladder Cancer

Sample size: 74 publication Evidence: moderate

Author Information

Author(s): JK Mellon, S Cook, P Chambers, DE Neal

Primary Institution: University of Newcastle upon Tyne

Hypothesis

The study aims to quantify levels of EGF and TGF-alpha in bladder cancers and correlate this information with EGFR levels.

Conclusion

Tumour samples had significantly higher levels of TGF-alpha compared to EGF, suggesting TGF-alpha is the likely ligand for EGFR in bladder tumours.

Supporting Evidence

  • TGF-alpha levels in malignant tissue were significantly higher than in benign bladder samples.
  • Mean TGF-alpha of malignant tissue was 9.50 ng/g compared to 0.78 ng/g for EGF.
  • EGF levels did not correlate with EGFR levels in the study.

Takeaway

This study looked at two important growth factors in bladder cancer and found that one of them, TGF-alpha, is much higher in cancerous tissue than in non-cancerous tissue.

Methodology

The study used radioimmunoassay techniques to measure EGF and TGF-alpha levels in bladder tissue samples from patients with bladder cancer.

Limitations

The study population had a relatively high proportion of muscle-invasive tumours, which may not represent all bladder cancer patients.

Participant Demographics

Patients with newly diagnosed bladder cancer requiring surgical resection or biopsy.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication